Rehabilitative Strategies Following Oesophageal Cancer (ReStOre)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03314311 |
Recruitment Status :
Completed
First Posted : October 19, 2017
Last Update Posted : October 19, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Esophageal Cancer | Behavioral: Rehabilitation programme | Not Applicable |

Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 44 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Rehabilitative Strategies Following Oesophageal Cancer |
Study Start Date : | October 2014 |
Actual Primary Completion Date : | June 2017 |
Actual Study Completion Date : | June 2017 |

Arm | Intervention/treatment |
---|---|
Experimental: Rehabilitation Programme
12 week multi-disciplinary intervention prescribing exercise, individual dietary counselling and education sessions.
|
Behavioral: Rehabilitation programme
The RESTORE trial is a 12 week multi-disciplinary intervention involving exercise, nutrition advice and education sessions |
No Intervention: Control
Usual care control arm
|
- Change in Aerobic Fitness [ Time Frame: Change from baseline in aerobic fitness at 12 weeks (end of intervention) ]Aerobic fitness (ml/kg/min) will be measured by maximal cardiopulmonary exercise test
- Change in physical activity levels [ Time Frame: Change from baseline in physical activity at 12 weeks (end of intervention) ]Physical activity (minutes per week) will be measured by accelerometry
- Change in hand grip strength [ Time Frame: Change from baseline in hand grip strength at 12 weeks (end of intervention) ]Hand grip strength (kg) will be measured by as an estimate of overall body strength
- Change in body Composition [ Time Frame: Change from baseline in body composition at 12 weeks (end of intervention) ]Segmental body composition will be measured by bioelectrical impedence analysis. Sarcopenia will be assessment by PET-CT
- Change in Dietary Intake [ Time Frame: Change from baseline in dietary intake at 12 weeks (end of intervention) ]Food frequency questionnaire
- Change in inflammatory status [ Time Frame: Change from baseline in inflammatory status at 12 weeks (end of intervention) ]Blood samples will be analysed for inflammatory cytokines (TNF-alpha and interleukin (IL)-6 as measured by multi-plex assays
- Change in energy metabolism [ Time Frame: Change from baseline in energy metabolism at 12 weeks (end of intervention) ]Blood samples will be analysed for measures of energy metabolism (citrate secretion and lactate secretion)
- Change in quality of Life [ Time Frame: Change from baseline in quality of life at 12 weeks (end of intervention) ]EORTC questionnaire will be used to measure QOL

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients who have completed treatment for oesophageal cancer to include oesophagectomy. Patients may have also been treated with neo-adjuvant or adjuvant chemotherapy or chemoradiotherapy.
- Curative treatment intent.
- Age >18 years
- Able to understand English
Exclusion Criteria:
- Evidence of active or recurrent disease

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03314311
Ireland | |
St James's Hospital | |
Dublin, Ireland, 8 |
Principal Investigator: | Juliette Hussey, PhD | University of Dublin, Trinity College |
Responsible Party: | Prof Juliette Hussey, Professor, University of Dublin, Trinity College |
ClinicalTrials.gov Identifier: | NCT03314311 |
Other Study ID Numbers: |
HRA-POR-2014-535 |
First Posted: | October 19, 2017 Key Record Dates |
Last Update Posted: | October 19, 2017 |
Last Verified: | October 2017 |
Rehabilitation Exercise Nutrition Therapy Patient Education as Topic |